Wed 9/18/2019 22:16 ET
DJIA27147.0835.290.13%TELCO186.810.930.50%GOLD1499.3016.491.10%Shanghai2978.447.150.24%
S&P 5003006.730.900.03%BANKS462.783.050.66%OIL58.160.120.21%BITCOIN10142.5021.300.21%
NASDAQ8177.399.000.11%PHARM554.402.000.36%US/EU1.100.000.00%Futures3003.125.410.18%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Wall Street Pit (Pressure BioSciences - PBIO)    Stock Due Diligence for All

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add PBIO
  
From: NetworkNewsWire (Rep: 0)Date: 06/12/2019 16:31
Forum: Wall Street Pit - Msg #2789946 - List PBIO msgs Thread #674085982 (Rec: 0)
NetworkNewsBreaks – Pressure BioSciences Inc.’s (PBIO) PCT Platform Prominently Featured in Record Number of ASMS Presentations
Company: Pressure BioSciences Inc. (PBIO)

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of high pressure-based instruments, consumables, and related services for the global life sciences and other industries worldwide, today announced its patented pressure cycling technology (“PCT”) platform was prominently featured in 15 independent presentations at the annual conference of the American Society for Mass Spectrometry (“ASMS”). The presentations at the ASMS conference, held from June 1-6, 2019 in Atlanta, Georgia, spanned PBI’s unique PCT platform’s wide ranging applications in scientific studies, particularly in advancing knowledge and understanding in such areas as cancer research, protein function, molecular biology, and biomarker discovery. “The number of PCT-related presentations at the 2019 ASMS conference significantly exceeded prior PBI records for a scientific meeting,” PBI’s Global Director of Sales & Marketing Roxana McCloskey said in the news release. “We are gratified that the use of our PCT platform continues to expand to new investigators and laboratories worldwide, and that its use has shown great promise in critical areas of human health, such as cancer. We believe the presentations at this prestigious annual meeting clearly show the increasing potential for the PCT platform in diagnostics and discovery, which we believe could eventually lead to the routine use of the PCT platform in precision medicine, a rapidly expanding market that is expected to reach $217 billion by 2028 (BIS Research, 2019).”

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser NetworkNewsWire: Reward | Watch | IgnorePBIO: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add PBIO
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.